New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

Fact checked by Nick Blackmer New research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and ...

Osteoporosis treatment following fragility fracture was associated with significantly reduced hospitalization and mortality risks among patients aged 80 years and older. After fracture at 80 years of ...

Please provide your email address to receive an email when new articles are posted on . “There is abundant evidence that men are not adequately screened for osteoporosis, and those with osteoporosis ...

As Washington pushes cheaper medicines through TrumpRx, Mark Cuban challenges the pharmaceutical middlemen, and big pharma pours billions into oral peptide technologies, Entera Bio ( NASDAQ:ENTX) is ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Individualized treatment for osteoporosis calls for a keen understanding of the patient’s frame ...

The reduced risk for hip fracture associated with osteoporosis treatment did not differ between men vs women. Osteoporosis treatment demonstrates similar efficacy for preventing hip fracture among men ...

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, ...

Osteoporosis treatment was associated with lower mortality and hospitalization rates among people older than 80 who had suffered fractures, according to a study presented at the Endocrine Society’s ...

I still feel some sharp sensations for a few seconds when starting to eat.

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...